GAINESVILLE, Fla.--(BUSINESS WIRE)--Quick-Med Technologies, Inc. announced today that Dr. Albina Mikhaylova, Senior Scientist at Quick-Med, presented conclusive evidence at the Symposium on Skin and Wound Care that the Company’s patented NIMBUS® antimicrobial technology poses no threat of bacterial resistance. The findings, presented in a podium session at this leading meeting of wound care practitioners, are in sharp contrast to known resistance issues with leading antibiotics that have allowed soaring hospital acquired infection rates seen worldwide.
